NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr | ₹223 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹225 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹223 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹225 Cr | 64.17 | |
| Mar2024 | ₹137 Cr | 113.53 | |
| Mar2023 | ₹64 Cr | -50.35 | |
| Mar2022 | ₹130 Cr | -42.03 | |
| Mar2021 | ₹223 Cr | - | |
Compare Capital Work in Progress of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,251.3 Cr | -2.1% | -29.6% | 0.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 1.5% | -3% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | -2.2% | -4.5% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0.8% | 2.3% | 43.9% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | 0.4% | -4% | -7.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.8% | -1.8% | -3.4% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2.1% |
-29.6% |
0.1% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses